home.aspx
 
EVENTS

Annual Psychopharmacology Update
ANNUAL PSYCHOPHARMACOLOGY UPDATE
December 04-05, 2020
Annual Psychopharmacology Update features the world's leading experts who will discuss the latest advances in the pharmacotherapy of anxiety disorders, mood disorders, schizophrenia, and more.

Pharmaceutical Drug Pricing Strategies Summit
PHARMACEUTICAL DRUG PRICING STRATEGIES SUMMIT
December 09-10, 2020
The Pharmaceutical Drug Pricing Strategies Summit is designed to bring senior pricing and reimbursement leaders to discuss the future of federal and state pricing requirements, transparency regulations, and strategic drug pricing models.

Boiron France / Boiron France

SHARESHARESHARE
Boiron is a family-owned and independent pharmaceutical company. We are specialized in the manufacture of homeopathic medicines of very high quality for a century. Present in more than 50 countries, with 3,708 employees, we develop with rigor and passion our project for health. Boiron is an independent, family-run pharmaceutical laboratory.
SHARESHARESHARE

RELATED NEWS


Swedish company Orexo has purchased the exclusive US rights to vorvida, a digital therapy to treat alcohol use disorder (AUD), from GAIA, for an undisclosed sum. In August, Orexo signed an agreement with GAIA to secure exclusive secure global commercial rights to OXD01, a digital therapy being developed to treat OUD. Under the deal, Orexo will take responsibility for the regulatory approval and commercialisation of vorvida digital therapy in the US. The deal allows GAIA to secure an upfront paym...

READ MORE

The US Food and Drug Administration (FDA) has approved a genetic test that can detect mutations in solid tumors in 324 genes. The test, known as F1CDx, uses next-generation sequencing to sequence DNA from a patient’s tumour sample and also detects two characteristics “genomic signatures”....

READ MORE

Obalon Therapeutics, Inc. a vertically integrated weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it has entered into a one-year agreement with Al Danah Medical Company (“Al Danah”) for distribution of the Obalon Navigation Balloon System in Qatar.  Obalon has terminated its agreement with Bader Sultan and Bros. Company for distribution of its prior-generation ball...

READ MORE

Janssen has struck a deal with Arrowhead Pharmaceuticals to develop an RNA interference drug to treat hepatitis B viral infection, worth up to $3.7 billion.
This year saw the first-ever approval of an RNA interference therapy – Alnylam’s Onpattro (patisiran) works by silencing a gene that causes the rare disease hereditary transthyretin-mediated amyloidosis (hATTR).
Janssen hopes to use the technology to silence the genetic material that allows hepatitis B to become est...


READ MORE

When dehydration strikes, part of the brain can swell, neural signaling can intensify, and do monotonous tasks can get harder. With the help of brain scans and a simple, repetitive task to test responsiveness, exercise physiologists at the Georgia Institute of Technology studied volunteer subjects who sweated a lot and did not hydrate. The fluid loss led most of the subjects to make more goofs on the task, and areas of participants' brains showed conspicuous changes. The researchers also fou...
GEORGIA INSTITUTE OF TECHNOLOGY
READ MORE

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the U.S. when compared with prices in the United Kingdom, Japan and the Canadian province of Ontario. The study also found that the longer the brand-name prescription drug was on the market, the greater the price differential. If the Medicare program used the same prices as these other countries, the estimated savings to Medicar...

READ MORE

EVENTS

Annual Psychopharmacology Update
ANNUAL PSYCHOPHARMACOLOGY UPDATE
December 04-05, 2020
Annual Psychopharmacology Update features the world's leading experts who will discuss the latest advances in the pharmacotherapy of anxiety disorders, mood disorders, schizophrenia, and more.

Pharmaceutical Drug Pricing Strategies Summit
PHARMACEUTICAL DRUG PRICING STRATEGIES SUMMIT
December 09-10, 2020
The Pharmaceutical Drug Pricing Strategies Summit is designed to bring senior pricing and reimbursement leaders to discuss the future of federal and state pricing requirements, transparency regulations, and strategic drug pricing models.